Last updated: August 17, 2026

 CANCER –  2025

 Dates: April 25, 2025


 Main topics:

This meeting will serve as a valuable forum for the presentation
and discussion of newly available data across various
 malignancies including all cancers.
 Participants will be provided with updates on practice-changing data
 in a practical and interactive format, fostering discussion,
 and impacting clinical outcomes for patients.

Programme:

Day 1 – Optimising Clinical Development in Oncology

    • Targeted therapies in clinical development; antibody, vaccines & cell-based therapies
  • Overcoming the mechanisms of cancer drug resistance
  • Co-development of combined oncology therapies
  • Identifying appropriate clinical endpoints
  • Strategies to reach critical go/no-go decisions earlier
  • Novel technologies for imaging in drug development
  • Pharmacovigilance & patient safety
  • Integrating biomarkers in clinical development & trials

Day 2 – Operational Challenges of Oncology Clinical Trials

    • Establishing the correct trial population; emerging markets, global  trials
  • Adaptive clinical trial design
  • Appropriate site selection
  • Regulatory considerations
  • Clinical trial management
  • Patient recruitment and retention strategies
  • Successfully maintaining CRO relationships
  • Effective use of clinical data & eClinical solutions

 

 

Call for abstracts

Deadline for submission: 10/09/2024

The late abstract should contain newly achieved scientific work and results. The abstract has to be one full page (size A4, 210 x 297 mm) plus 1 to 3 explanatory pages with more detailed information about the work.
The abstract written in English and single spaced should include:

  • Applicable topic
  • Full title
  • Full name, affiliation, address, phone/fax/e-mail of one author for all correspondence
  • For all other co-authors, full name, affiliation and e-mail
  • Short introductive summary (approx. 1,000 characters) for publication in the   Programme Planner
  • Purpose of the work
  • Approach
  • Scientific innovation and relevance
  • Results and Conclusions

For questions concerning abstracts, please contact:

 [email protected]

[email protected]

The attendees of this event will get a chance to take part in:

  • master class on modern instrumental methods of diagnostics of rheumatic diseases- ultrasounds, MRI, osseo densitometry.
  • master class on increasing effective drug treatment of patients with rheumatic diseases.

 Conditions of participation for participants:

Registration Package   includes   certificate of participation (English language) ,participation in scientific sessions, conference materialsvisit to the exhibition and 10-30% discount for accomodation in hotel.

Online registration is required.No admission without registration confirmation.

nbscience

(deadline – November 01, 2024)

Contact NBScience’s

Education/Conference Department:

[email protected]

pharmacology

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

WhatsApp